{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2929, 
        2935
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2913, 
        2927
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2343, 
        2366
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3434, 
        3454
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2560, 
        2587
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        526, 
        555
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1941, 
        1976
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3212, 
        3238
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2639, 
        2662
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2717, 
        2740
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2826, 
        2849
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3106, 
        3129
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3185, 
        3208
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2904, 
        2912
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2981, 
        2987
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3242, 
        3250
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3276, 
        3284
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3308, 
        3316
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3341, 
        3349
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3373, 
        3381
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3404, 
        3412
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2608, 
        2618
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2687, 
        2696
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2765, 
        2775
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2874, 
        2883
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3077, 
        3085
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3154, 
        3163
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2589, 
        2590
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 9^9999^MOH|PIMS|CCO|20160512170639|C05BDE1D4D0D85F7B2CCF5DBD80547DBCCF37778|ORU^R01|Q246559815|P|2.5|\nPID|1||99999^^^^CMR^HOSPITAL 9&9999&MOH~~99999^^^^MRN^HOSPITAL 9&9999&MOH~9999999999&TD&ON^^^^JHN||XXXXXXXX^XXXXX^XXXXXXXX||99999999|M|||999X 99XX XXX^^XXXXXXX^XX^X9X9X9^999||(999)999-9999|||||||||||||||||N|\nOBR|1||S-16-003552|11529-5^Surgical Pathology Study Report^LN^P^Pathology^L|||20160505|||72368^XXXXXXX^XXXX||||||99999^XXXXXXX^XXXX||||N||20160512|||F|||||||99999^XXXXXXX^XXXXXX|\n\n\n\n\n\n\n\nPath report.gross description\n\n1. The specimen container is labelled with the patient?s demographics and \"right lobe base\"\". The specimen consists of two tan core fragments measuring 1.4 cm and 2.0 cm. The specimen is submitted in toto.nE\nE\\2. The specimen container is labelled with the patient?s demographics and \"right lobe mid\". The specimen consists of two tan core fragments measuring 1.6 cm and 1.7 cm. The specimen is submitted in toto.nE\nE\\3. The specimen container is labelled with the patient's demographics and \"right lobe apex\". The specimen consists of four yellow-white core fragments of tissue having a combined length of 3.0 cm. The tissue is submitted in toto in cassette #3.nE\nE\\4. The specimen container is labelled with the patient?s demographics and \"left lobe base\". The specimen consists of two tan core fragments measuring 1.9 cm and 2.0 cm. The specimen is submitted in toto.nE\nE\\5. The specimen container is labelled with the patient's demographics and \"left lobe mid\". The specimen consists of three yellow-white core fragments of tissue having a combined length of 3.5 cm. The tissue is submitted in toto in cassette #5.nE\nE\\6. The specimen container is labelled with the patient's demographics and \"left lobe apex\". The specimen consists of four to five yellow-white core fragments of tissue having a combined length of 3.4 cm. The tissue is submitted in toto in cassette #6.nE\nE\\TC\n\n\nPath report.microscopic observation\n\n6. There are foci of high-grade prostatic intraepithelial neoplasia. Triple-staining immunohistochemistry has been performed on part #6. There is preservation of basal cell immunostaining and positive racemase immunostaining in the areas of high-grade prostatic intraepithelial neoplasia. There is no evidence of invasive malignancy in original or deeper levels.\n\n\nPath report.relevant Hx\n\n1. - 6. Biopsy: YesnE\\Ischemic Time: < 1 minnE\\Time in Fixative/Formalin: 05-May-2016 11:21 / 11:22 / 11:23 / 11:24 / 11:25 / 11:26nE\\Total Fixation Time: 77.5 hoursnE\\Clinical History: ?CA\n\n\nPath report.final diagnosis\n\n1. Prostate gland, right base, core biopsies:nE\\- Negative for malignancy.nE\nE\\2. Prostate gland, right mid, core biopsies:nE\\- Negative for malignancy.nE\nE\\3. Prostate gland, right apex, core biopsies:nE\\- Focal acute inflammation;nE\\- Negative for malignancy.nE\nE\\4. Prostate gland, left base, core biopsies:nE\\- Invasive adenocarcinoma (acinar, not otherwise specified);nE\\- Gleason score 7(4+3)/10;nE\\- Involving 2/2 cores;nE\\- 25% and 6% surface involvement. nE\nE\\5. Prostate gland, left mid, core biopsies:nE\\- Negative for malignancy.nE\nE\\6. Prostate gland, left apex, core biopsies: nE\\- Negative for malignancy.\n\n\nPath report.site of origin\n\n1 Prostate Bx Right Lobe #1BASEnE\\2 Prostate Bx Right Lobe#2MIDnE\\3 Prostate Bx Right Lobe#3APEXnE\\4 Prostate Bx Left Lobe#4BASEnE\\5 Prostate Bx Left Lobe#5MIDnE\\6 Prostate Bx Left Lobe#6APEX\n\n\nPath report.comments\n\nProstate Gland Biopsy Case Summary 1 - 6 nE\nE\\Procedure: Prostate Gland BiopsiesnE\\Tumor Histologic Type: Adenocarcinoma (acinar, not otherwise specified)nE\\Gleason Grade: nE\\ Primary Pattern: 4nE\\ Secondary Pattern: 3nE\\ Total Gleason Score: 7nE\\Relative Percentage Gleason pattern 4 and/or 5: 60%nE\\Extent:nE\\ Number of positive cores: 2nE\\ Total number of Cores: 12nE\\ Proportion (percent) of prostatic tissue involved by tumor: 3%nE\\Periprostatic Fat Invasion: AbsentnE\\Seminal Vesicle Invasion: AbsentnE\\Additional Pathologic FindingsnE\\ Intraductal carcinoma: AbsentnE\\ Lymph-Vascular Invasion: AbsentnE\\ Perineural Invasion: AbsentnE\\ Ancillary Studies: Triple-staining immunohistochemistry using p63/34betaE12/racemase has been performed on part #4 (left base). There is loss of basal cell immunostaining and positive racemase staining in the areas of invasive malignancy in part #4 (left base). nE\nE\\Internal pathology consultation has been completed for part #4 of this case.\n\n\n"
}